1. Chaudhary N, Mohan B, Kaur H, Modgil V, Kant V, Bhatia A, Taneja N. Vibrio Phage VMJ710 Can Prevent and Treat Disease Caused by Pathogenic MDR V. cholerae O1 in an Infant Mouse Model. Antibiotics. 2023 Mar 14;12(6):1046.
2. Chaudhary N, Maurya RK, Singh D, Mohan B, Taneja N. Genome Analysis and Antibiofilm Activity of Phage 590B against Multidrug-Resistant and Extensively Drug-Resistant Uropathogenic Escherichia coli Isolates, India. Pathogens. 2022 Dec;11(12):1448.
3. Chaudhary N, Mohan B, Mavuduru RS, Kumar Y, Taneja N. Characterization, genome analysis and in vitro activity of a novel phage vB_EcoA_RDN8. 1 active against multi‐drug resistant and extensively drug‐resistant biofilm‐forming uropathogenic Escherichia coli isolates, India. Journal of Applied Microbiology. 2022 Apr;132(4):3387-404.
4. Chaudhary N, Singh D, Maurya RK, Mohan B, Taneja N. Complete Genome Sequence of Salmonella Phage vB_SenA_SM5, Active against Multidrug-Resistant Salmonella enterica Serovar Typhi Isolates. Microbiology Resource Announcements. 2022 Jul ;11(7):e00309-22
5. Chaudhary N, Singh D, Maurya RK, Mohan B, Mavuduru RS, Taneja N. Whole genome sequencing and in vitro activity data of Escherichia phage NTEC3 against multidrug-resistant Uropathogenic and extensively drug-resistant Uropathogenic E. coli isolates. Data in brief. 2022 Aug 1;43:108479.
6. Chaudhary N, Singh D, Narayan C, Samui B, Mohan B, Mavuduru RS, Taneja N. Complete Genome Sequence of Escherichia Phage 590B, Active against an Extensively Drug-Resistant Uropathogenic Escherichia coli Isolate. Microbiology Resource Announcements. 2021 Sep;10(38):e00550-21.
7. Chaudhary N, Narayan C, Mohan B, Taneja N. Characterization and in vitro activity of a lytic phage RDN37 isolated from community sewage water active against MDR Uropathogenic E. coli. Indian Journal of Medical Microbiology. 2021 Jul ;39(3):343-8.
8. Chaudhary N, Mohan B, Taneja N. Draft Genome Sequence of Escherichia Phage PGN829. 1, Active against Highly Drug-Resistant Uropathogenic Escherichia coli. Microbiol Resour Announc. 2018 Nov ;7(20):e01141-18.
9. Kaur H, Kalia M, Chaudhary N, Singh V, Yadav VK, Modgil V, Kant V, Mohan B, Bhatia A, Taneja N. Repurposing of FDA approved drugs against uropathogenic Escherichia coli: In silico, in vitro, and in vivo analysis. Microbial Pathogenesis. 2022 Aug ;169:105665.
10. Modgil V, Narayan C, Kaur H, Yadav VK, Chaudhary N, Kant V, Mohan B, Bhatia A, Taneja N. Analysis of the virulence and inflammatory markers elicited by Enteroaggregative Escherichia coli isolated from clinical and non-clinical sources in an experimental infection model, India. Microbiology Research. 2022 Nov 4;13(4):882-97.
11. Kaur H, Modgil V, Chaudhary N, Mohan B, Taneja N. Computational Guided Drug Targets Identification against Extended-Spectrum Beta-Lactamase-Producing Multi-Drug Resistant Uropathogenic Escherichia coli. Biomedicines. 2023 Feb 19;11(7):2028.

Naveen Chaudhary, Neelam Taneja. Novel bacteriophage and antibacterial composition comprising thereof.